financetom
Business
financetom
/
Business
/
Endeavor Group's Q4 Loss Widens, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Endeavor Group's Q4 Loss Widens, Revenue Rises
Feb 27, 2025 5:43 AM

08:17 AM EST, 02/27/2025 (MT Newswires) -- Endeavor Group Holdings ( EDR ) reported Wednesday its Q4 loss widened to $0.64 per diluted share from a loss of $0.03 a year earlier.

Two analysts polled by FactSet expected earnings of $0.14.

Revenue for the quarter ended Dec. 31 was $1.57 billion, up from $1.47 billion a year earlier.

Four analysts surveyed by FactSet expected $1.52 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump Warns of 50% Tariffs on Imported Steel, Aluminum; Partners Threaten Countermeasures
Trump Warns of 50% Tariffs on Imported Steel, Aluminum; Partners Threaten Countermeasures
Jun 2, 2025
05:51 AM EDT, 06/02/2025 (MT Newswires) -- US President Donald Trump threatened Friday to raise steel tariffs to 50% from a previous import duty of 25%, effective June 4. Our steel and aluminum industries are coming back like never before, he said in a post on his Truth Social account. This will be yet another BIG jolt of great news...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Novartis Says Pluvicto Shows Benefit in Early Prostate Cancer Study
Novartis Says Pluvicto Shows Benefit in Early Prostate Cancer Study
Jun 2, 2025
05:59 AM EDT, 06/02/2025 (MT Newswires) -- Novartis ( NVS ) said Monday that its radioligand therapy, Pluvicto, combined with standard care, significantly improved radiographic progression-free survival in a pre-specified interim analysis of a phase 3 trial for patients with a certain type of prostate cancer. The drugmaker said a positive trend in overall survival was also observed. ...
Kura Oncology, Kyowa Get FDA Acceptance, Priority Review of New Drug Application for Ziftomenib
Kura Oncology, Kyowa Get FDA Acceptance, Priority Review of New Drug Application for Ziftomenib
Jun 2, 2025
05:54 AM EDT, 06/02/2025 (MT Newswires) -- Kura Oncology ( KURA ) and Kyowa Kirin said Sunday that the US Food and Drug Administration has accepted Kura's new drug application seeking full approval for ziftomenib to treat relapsed or refractory acute myeloid leukemia in adult patients. The company said the agency granted the application priority review and assigned a prescription...
Copyright 2023-2026 - www.financetom.com All Rights Reserved